Full Text View
Tabular View
No Study Results Posted
Related Studies
Improving Cardiac Rehabilitation Participation in Women and Men
This study is ongoing, but not recruiting participants.
Study NCT00336830   Information provided by Lawson Health Research Institute
First Received: June 13, 2006   Last Updated: July 25, 2008   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

June 13, 2006
July 25, 2008
May 2003
Attendance at initial CR orientation appointment within 2 months of index hospital discharge [ Time Frame: 3 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00336830 on ClinicalTrials.gov Archive Site
  • Impact of MD endorsement on number of patients attending CR program [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • Number of patients who continue to adhere to the 6-month CR program beyond the initial CR orientation appointment [ Time Frame: 8 months ] [ Designated as safety issue: No ]
  • Impact of other patient variables and how they influence participation in a CR program [ Time Frame: 8 months ] [ Designated as safety issue: No ]
  • Impact of MD endorsement on number of patients attending CR program.
  • Number of patients who continue to adhere to the 6-month CR program beyond the initial CR Orientation appointment.
  • Impact of other patient variables and how they influence participation in a CR program.
 
Improving Cardiac Rehabilitation Participation in Women and Men
Improving Cardiac Rehabilitation Participation in Women and Men

The purpose of this study is to determine the effect of a pre-discharge written personal endorsement to the patient by the patient's attending cardiologist or cardiac surgeon (MD endorsement) to take part in the Cardiac Rehabilitation and Secondary Prevention (CR) program, in addition to the standard CR referral, compared to the standard CR referral alone, on CR program enrollment within 2 months of index hospital discharge following admission for myocardial infarction, unstable angina, coronary angioplasty, or coronary artery bypass.

There is compelling evidence that a comprehensive CR program comprising the delivery of lifestyle modifying education will reduce mortality, morbidity and improve quality of life in patients following myocardial infarction, angioplasty or, coronary artery bypass. However, less than 20% of eligible patients participate in CR programs. This study will look at a method of potentially improving enrollment and adherence to a CR program. It is expected that patients who receive the MD-endorsed referral will be more likely to attend the initial Orientation appointment and more closely adhere to the 6-month comprehensive CR program, as compared to the patients who receive a standard CR referral alone.

Phase III
Interventional
Other, Randomized, Single Blind (Subject), Active Control, Parallel Assignment, Efficacy Study
  • Myocardial Infarction
  • Unstable Angina
  • Coronary Disease
  • Behavioral: MD-endorsed Cardiac Rehabilitation referral
  • Behavioral: Standard Cardiac Rehabilitation referral
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
1035
December 2008
June 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient is admitted to hospital for myocardial infarction (MI), unstable angina (UA), percutaneous transluminal coronary angioplasty (PTCA), or coronary artery bypass surgery (CABS)
  • Patient resides within 1 hour driving time from London

Exclusion Criteria:

  • Inability to provide written informed consent or complete survey due to language or cognitive difficulties
  • Previous cardiac rehabilitation participation
  • Patient scheduled to undergo PTCA or CABS within two months following the index hospital discharge
  • Inability to exercise due to musculoskeletal problems or previous or current stroke
Both
18 Years and older
Yes
 
Canada
 
 
NCT00336830
Dr. Neville Suskin, Lawson Health Research Institute
CIHR 56926
Lawson Health Research Institute
  • Canadian Institutes of Health Research (CIHR)
  • AstraZeneca
Principal Investigator: Neville Suskin, MBChB, MSc University of Western Ontario & London Health Sciences Centre
Lawson Health Research Institute
July 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.